Market by Product, Application, End-user, and Country | Forecast 2021-2028
Triton’s report assesses the
pharmaceutical continuous manufacturing market in Latin America to witness
growth at a CAGR of 10.66% over the considered years of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in
this market include:
• Brazil
• Mexico
• Rest of Latin America
In Latin America, the studied
market is evaluated to develop gradually during the forecast period, owing to
the surged healthcare expenditure. Among the countries, Mexico’s pharmaceutical
sector has gained significant traction over the years. The country became one
of the key exporters of pharmaceutical products to the United States and Europe
under the Free Trade Agreement. Furthermore, the COVID-19 outbreak increased
the development of more drugs, which is another factor that has fueled the
progress of the pharmaceutical continuous manufacturing market across Mexico.
Furthermore, Brazil’s
pharmaceutical industry is among the largest, based on sales revenue. Here,
prescription drugs are considered to account for half the sales, followed by
over-the-counter and generic medications. Additionally, the country offers
universal healthcare benefits to all citizens under its national healthcare
program, further strengthening the pharmaceutical sector’s development. Also,
over the years, the pharmaceutical industry has transformed significantly,
having well-developed infrastructure with modern equipment. Hence, these
developments are likely to enhance the need for continuous manufacturing,
thereby widening the scope and growth of Brazil’s pharmaceutical continuous
manufacturing market across Brazil.
In Rest of Latin America,
Argentina is considered to host a well-developed pharmaceutical industry, with
domestic production accounting for a significant share in terms of volume.
Moreover, government support is another factor expected to influence the
pharmaceutical industry to invest in generic drugs. Hence, these factors are
predicted to stimulate the growth of the pharmaceutical continuous
manufacturing market.
Siemens Healthineers is engaged
in the manufacturing of medical, surgical, and veterinary equipment. Moreover,
the company is considered to be among the market leaders in terms of imaging
systems, further establishing designs of MRI, molecular imaging, ultrasound,
and others. Its process analytical technology offers the technological base
required for continuous manufacturing. The company has operations in several
regions, including Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
2.3. MARKET
ATTRACTIVENESS INDEX
2.4. VENDOR
SCORECARD
2.5. KEY
INSIGHTS
2.6. MARKET
DRIVERS
2.6.1. RISE
IN INITIATIVES BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS
MANUFACTURING
2.6.2. SURGING
ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
2.6.3. RISING
HEALTHCARE EXPENDITURE
2.7. MARKET
RESTRAINTS
2.7.1. LACK
OF DEMAND FOR PCM SYSTEMS IN UNDERDEVELOPED ECONOMIES
2.7.2. RISING
CUSTOMER EXPECTATIONS FOR BETTER MEDICINES
2.8. MARKET
OPPORTUNITIES
2.8.1. INCREASING
OPPORTUNITIES IN THE UNTAPPED EMERGING ECONOMIES
2.8.2. SURGE
IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS
3. LATIN
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT
3.1. INTEGRATED
CONTINUOUS SYSTEM
3.2. SEMI-CONTINUOUS
SYSTEM
3.3. CONTROL
& SOFTWARE
4. LATIN
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION
4.1. FINAL
DRUG PRODUCT MANUFACTURING
4.2. API
MANUFACTURING
5. LATIN
AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER
5.1. PHARMACEUTICAL
COMPANIES
5.2. CONTRACT
MANUFACTURING ORGANIZATIONS
5.3. OTHER
END-USERS
6. PHARMACEUTICAL
CONTINUOUS MANUFACTURING MARKET - LATIN AMERICA
6.1. COUNTRY
ANALYSIS
6.1.1. MEXICO
6.1.2. BRAZIL
6.1.3. REST
OF LATIN AMERICA
7. COMPANY
PROFILE
7.1. HOSOKAWA
MICRON CORPORATION
7.2. GEA
GROUP AG
7.3. LB
BOHLE MASCHINEN + VERFAHREN GMBH
7.4. THERMO
FISHER SCIENTIFIC INC
7.5. SIEMENS
HEALTHINEERS
7.6. ELI
LILLY & COMPANY
7.7. PFIZER
INC
7.8. GLATT
GMBH
7.9. SYNTEGON
(FORMERLY BOSCH PACKAGING TECHNOLOGY)
7.10. GEBRUDER
LODIGE MASCHINENBAU GMBH
7.11. KORSCH
AG
7.12. COPERION
GMBH
7.13. MUNSON
MACHINERY COMPANY
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 3: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 4: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 3: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $
MILLION)
FIGURE 6: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $
MILLION)
FIGURE 9: LATIN AMERICA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 10: MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 11: BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 12: REST OF LATIN AMERICA PHARMACEUTICAL
CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)